Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of responseVOLLENHOVEN, Ronald F.van; PETRI, Michelle A; CERVERA, Ricard et al.Annals of the rheumatic diseases. 2012, Vol 71, Num 8, pp 1343-1349, issn 0003-4967, 7 p.Article

Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359GULICK, Roy M; HU, X. Joan; SNYDER, Sally et al.The Journal of infectious diseases. 2002, Vol 186, Num 5, pp 626-633, issn 0022-1899, 8 p.Article

Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir : AIDS Clinical Trials Group Study 359GULICK, Roy M; HU, X. Joan; SNYDER, Sally et al.The Journal of infectious diseases. 2000, Vol 182, Num 5, pp 1375-1384, issn 0022-1899Article

Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging StudySTOHL, William; MERRILL, Joan T; MCKAY, James D et al.Journal of rheumatology. 2013, Vol 40, Num 5, pp 579-589, issn 0315-162X, 11 p.Article

Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samplesLARDER, Brendan A; HERTOGS, Kurt; BLOOR, Stuart et al.AIDS (London). 2000, Vol 14, Num 13, pp 1943-1948, issn 0269-9370Article

A phase 1 study of PAmAb, a fully human monoclonal antibody against Bacillus anthracis protective antigen, in healthy volunteersSUBRAMANIAN, G. Mani; CRONIN, Patrick W; POLEY, Gerald et al.Clinical infectious diseases. 2005, Vol 41, Num 1, pp 12-20, issn 1058-4838, 9 p.Article

Long-Term Safety Profile of Belimumab Plus Standard Therapy in Patients With Systemic Lupus ErythematosusMERRILL, Joan T; GINZLER, Ellen M; PINEDA, Lilia et al.Arthritis and rheumatism. 2012, Vol 64, Num 10, pp 3364-3373, issn 0004-3591, 10 p.Article

A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patientsBAIN, Vincent G; KAITA, Kelly D; FREIMUTH, William W et al.Journal of hepatology. 2006, Vol 44, Num 4, pp 671-678, issn 0168-8278, 8 p.Article

Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients : Evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trialJOLY, Véronique; MORONI, Mauro; WILKINS, Edmund G. L et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 11, pp 3155-3157, issn 0066-4804Article

Belimumab Reduces Autoantibodies, Normalizes Low Complement Levels, and Reduces Select B Cell Populations in Patients With Systemic Lupus ErythematosusSTOH, William; HIEPE, Falk; PINEDA, Lilia et al.Arthritis and rheumatism. 2012, Vol 64, Num 7, pp 2328-2337, issn 0004-3591, 10 p.Article

Effect of Belimumab on Vaccine Antigen Antibodies to Influenza, Pneumococcal, and Tetanus Vaccines in Patients with Systemic Lupus Erythematosus in the BLISS-76 TrialWINN CHATHAM, W; WALLACE, Daniel J; ZHONG, Z. John et al.Journal of rheumatology. 2012, Vol 39, Num 8, pp 1632-1640, issn 0315-162X, 9 p.Article